Veterinary Medicines

Heptavac P plus

Authorised
  • Clostridium chauvoei, toxoid
  • Clostridium chauvoei, strain 1048, cells and equivalent toxoid
  • Clostridium chauvoei, strain 658, cells and equivalent toxoid
  • Clostridium chauvoei, strain 657, cells and equivalent toxoid
  • Clostridium chauvoei, strain 656, cells and equivalent toxoid
  • Clostridium chauvoei, strain 655, cells and equivalent toxoid
  • Tetanus toxoid adsorbed
  • Clostridium septicum, toxoid
  • Clostridium perfringens, type C, strain 578, beta toxoid
  • Clostridium perfringens, type C, strain 554, beta toxoid
  • Clostridium novyi, toxoid
  • Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated
  • Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated
  • Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated
  • Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
  • Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated
  • Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated
  • Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated
  • Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated
  • Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated
Download as PDF

Product identification

Medicine name:
Heptavac P plus
Active substance:
  • Clostridium chauvoei, toxoid
  • Clostridium chauvoei, strain 1048, cells and equivalent toxoid
  • Clostridium chauvoei, strain 658, cells and equivalent toxoid
  • Clostridium chauvoei, strain 657, cells and equivalent toxoid
  • Clostridium chauvoei, strain 656, cells and equivalent toxoid
  • Clostridium chauvoei, strain 655, cells and equivalent toxoid
  • Tetanus toxoid adsorbed
  • Clostridium septicum, toxoid
  • Clostridium perfringens, type C, strain 578, beta toxoid
  • Clostridium perfringens, type C, strain 554, beta toxoid
  • Clostridium novyi, toxoid
  • Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated
  • Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated
  • Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated
  • Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
  • Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated
  • Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated
  • Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated
  • Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated
  • Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated
Target species:
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium chauvoei, toxoid
    1.00
    90% protective dose in guinea pig
    /
    2.00
    millilitre(s)
  • Clostridium chauvoei, strain 1048, cells and equivalent toxoid
    1.00
    90% protective dose in guinea pig
    /
    2.00
    millilitre(s)
  • Clostridium chauvoei, strain 658, cells and equivalent toxoid
    1.00
    90% protective dose in guinea pig
    /
    2.00
    millilitre(s)
  • Clostridium chauvoei, strain 657, cells and equivalent toxoid
    1.00
    90% protective dose in guinea pig
    /
    2.00
    millilitre(s)
  • Clostridium chauvoei, strain 656, cells and equivalent toxoid
    1.00
    90% protective dose in guinea pig
    /
    2.00
    millilitre(s)
  • Clostridium chauvoei, strain 655, cells and equivalent toxoid
    1.00
    90% protective dose in guinea pig
    /
    2.00
    millilitre(s)
  • Tetanus toxoid adsorbed
    2.50
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium septicum, toxoid
    2.50
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, type C, strain 578, beta toxoid
    10.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, type C, strain 554, beta toxoid
    10.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium novyi, toxoid
    3.50
    international unit(s)
    /
    2.00
    millilitre(s)
  • Bibersteinia trehalosi, serotype T15, strain S1105/84, Inactivated
    1000000000.00
    cells
    /
    2.00
    millilitre(s)
  • Bibersteinia trehalosi, serotype T10, strain S1075/81, Inactivated
    1000000000.00
    cells
    /
    2.00
    millilitre(s)
  • Bibersteinia trehalosi, serotype T4, strain S1085/81, Inactivated
    1000000000.00
    cells
    /
    2.00
    millilitre(s)
  • Bibersteinia trehalosi, serotype T3, strain S1109/84, Inactivated
    1000000000.00
    cells
    /
    2.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A9, strain S994/77, Inactivated
    1000000000.00
    cells
    /
    2.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A7, strain S1078/81, Inactivated
    1000000000.00
    cells
    /
    2.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A6, strain S1084/81, Inactivated
    1000000000.00
    cells
    /
    2.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A2, strain S1126/92, Inactivated
    1000000000.00
    cells
    /
    2.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A1, strain S1006/77, Inactivated
    1000000000.00
    cells
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 73a/97
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 27/02/2024
Download